Developing and Implementing Meaningful Activities Facilitators in Geriatric Short Stay
NCT ID: NCT06080126
Last Updated: 2023-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
320 participants
INTERVENTIONAL
2023-10-30
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives: The investigators objective is to study the feasibility and acceptability of integrating MAFs into the care teams of two geriatric short-stay services in France. The investigators will evaluate the adaptations to be proposed to the MAF model to make it relevant in our context from the point of view of patients, their relatives and professionals, and will study the effect of this intervention on the occurrence of complications and the functioning of the teams, its implementation and its costs.
Perspectives: The results of this study will allow us to define if the MAFs intervention is feasible and acceptable in the French context, and if so, to propose an intervention model adapted to our context.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary
NCT05659706
Clinical and Medico-economic Evaluation of Taken Care Associating Nutritional Support and Adapted Physical Activity for Malnourished, or at Risk of Undernutrition, Elderly People on Discharge From Hospital
NCT03979560
Assessment of Food Practices by Residents in Nursing Homes
NCT02626078
Effectiveness of a Patient-oriented Discharge Summary
NCT06123546
Impact of a Dedicated Geriatric Sector on the Loss of Functional Autonomy at 1 Month for Patients Admitted to Emergencies and Non-hospitalised
NCT04970784
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The results will allow us to propose phase 3 of the MRC recommendations, a multicenter randomized controlled evaluation in clusters, informed by the results for the content of the intervention, the implementation strategies, the choice of the primary endpoint, the inclusion criteria of the population, the calculation of the sample size and the study procedures (inclusion, data collection).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
* Phase 1: The adaptation of the intervention to our context will be based on a literature review and a qualitative study.
* Phase 2: The feasibility and acceptability of the intervention will be assessed during a quasi-experimental before and after study conducted in two short-stay geriatric units.
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Control: per usual practice
160 patients were included as per usual practice.
Intervention
Intervention MAF
160 patients were included with MAF intervention.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control: per usual practice
160 patients were included as per usual practice.
Intervention MAF
160 patients were included with MAF intervention.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* admitted to a geriatric short-stay hospital for \> 72 hours
* Considered "at risk of complications related to hospitalisation": at least two of the following criteria:
* Clinical Frailty Scale (Rockwood Clinical Frailty Score
* At least one ADL-IADL dependency,
* Presence of known cognitive impairment,
* Patient confused on admission,
* History of confusional syndrome on previous hospitalisation or use of medication,
* Anxiety-depression (history or current pathology),
* Repeated falls (\>2 in a year) or fear of falling,
* Risk of sarcopenia (Score \>4 on the SARC-F questionnaire
* Presenting undernutrition or a risk of undernutrition (according to medical assessment, e.g. low BMI, anorexia, recent weight loss).
* Patient having been informed of the study and having signed an informed consent (for patients under guardianship, the consent of the guardian will be requested). For patients under guardianship, the patient will sign the consent in the presence of the guardian.
* Patient who understands and speaks French
* Patient affiliated to a social security scheme
Exclusion Criteria
* Re-hospitalised patients already included during a previous stay
* Patients under court protection
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geriatric Short Stay Department - Unit 3C of the Charpennes Hospital
Lyon, , France
University Department of Geriatric Medicine, Centre Hospitalier Lyon Sud
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A00490-45
Identifier Type: REGISTRY
Identifier Source: secondary_id
69HCL22_0726
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.